Bank of America’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Bank of America’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,500	Closed	-$156K	–	7348
2019 Q4	$156K	Buy	+2,500	New	+$119K	﹤0.01%	5770

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Bank of America's DCPH Position: Q2 2024 in Review

Bank of America sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 223,187 shares — an estimated $3.51M sold.

Bank of America first reported a position in DCPH in Q4 2017 and held it in 26 quarters. The position peaked at $29.5M in Q4 2021. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Bank of America reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Bank of America sold 223,187 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $3.51M.
Bank of America first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 26 quarters.
Bank of America's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $29.5M in Q4 2021.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Bank of America's 13F filing for Q2 2024, filed 14 Aug 2024.